Cargando…
Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study
To evaluate association of carcinoid syndrome (CS) symptom burden and somatostatin analog (SSA) duration with quality of life (QoL) using Functional Assessment of Cancer Therapy-General (FACT-G) and Patient-Reported Outcomes Measurement Information System (PROMIS-29) instruments. Adults who received...
Autores principales: | Halperin, Daniel M., Huynh, Lynn, Beaumont, Jennifer L., Cai, Beilei, Totev, Todor, Bhak, Rachel H., Duh, Mei S., Neary, Maureen P., Cella, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392719/ https://www.ncbi.nlm.nih.gov/pubmed/30461659 http://dx.doi.org/10.1097/MD.0000000000013390 |
Ejemplares similares
-
Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome
por: Halperin, Daniel M., et al.
Publicado: (2019) -
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
por: Metz, David C, et al.
Publicado: (2020) -
The Carcinoid Syndrome
por: Strahan, Jack
Publicado: (1961) -
The Carcinoid Syndrome
Publicado: (1973) -
Management of Diarrhea in Patients With Carcinoid Syndrome
por: Naraev, Boris G., et al.
Publicado: (2019)